FiercePharmaESMO: Moderna, BioNTech's post-COVID futures in oncology hit manufacturing realitiesOct 24, 2023Annalee ArmstrongBy Annalee Armstrongmore_vert
Nature.comCLDN6-specific CAR-T cells plus amplifying RNA vaccine in relapsed or refractory solid tumors: the phase 1 BNT211 ...Oct 23, 2023Peter Hillemanns, Uğur Şahin & Alexander DesukiBy Peter Hillemanns, Uğur Şahin & Alexander Desukimore_vert